Atea Pharmaceuticals annual free cash flow
2018
2019
2020
2021
2022
Atea Pharmaceuticals Free Cash Flow (FCF) History (AVIR)
Atea Pharmaceuticals reported −$122.9M in free cash flow for fiscal 2022, a decrease of $35.9M from the previous fiscal year.
View full Atea Pharmaceuticals company overviewAtea Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$122.9M | −$35.9M | — | — |
| 2021 | 2021-12-31 | −$87.0M | −$383.7M | — | −24.76% |
| 2020 | 2020-12-31 | $296.7M | $309.5M | — | +610.10% |
| 2019 | 2019-12-31 | −$12.8M | −$4.9M | — | — |
| 2018 | 2018-12-31 | −$7.9M | — | — | — |
Atea Pharmaceuticals quarterly free cash flow
Q3.20
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2022 | 2022-12-31 | −$21.5M | −$12.0M | — | — |
| Q3 2022 | 2022-09-30 | −$21.3M | — | — | — |
| Q2 2022 | 2022-06-30 | −$21.1M | — | — | — |
| Q1 2022 | 2022-03-31 | −$59.1M | — | — | — |
| Q3 2020 | 2020-09-30 | −$9.5M | — | — | — |
Atea Pharmaceuticals free cash flow growth trends
Atea Pharmaceuticals's latest reported quarter, Q4 2022, generated −$21.5M in free cash flow, a decrease of $12.0M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Atea Pharmaceuticals filings at SEC.gov ↗